Projects per year
Fingerprint Dive into the research topics where James D Lechleiter is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 2 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
Regulation of ER-stress Activated UPR kinase PERK in Neurodegenerative Diseases
Project: Research project
ASTROCYTE ACTIVATION BY SMALL MOLECULE P2Y1 AGONISTS FOR TREATMENT OF TBI
9/30/15 → 6/30/17
Project: Research project
San Antonio Biomedical Education and Research
Lechleiter, J. D., McManus, L. M., Mcmanus, L. M. & Oyajobi, B.
7/1/15 → 3/31/20
Project: Research project
Research Output
A Mouse Model of Repetitive Blast Traumatic Brain Injury Reveals Post-Trauma Seizures and Increased Neuronal Excitability
Bugay, V., Bozdemir, E., Vigil, F. A., Chun, S. H., Holstein, D. M., Elliott, W. R., Sprague, C. J., Cavazos, J. E., Zamora, D. O., Rule, G., Shapiro, M. S., Lechleiter, J. D. & Brenner, R., Jan 15 2020, In : Journal of Neurotrauma. 37, 2, p. 248-261 14 p.Research output: Contribution to journal › Article
4
Scopus
citations
Prevention of brain damage after traumatic brain injury by pharmacological enhancement of KCNQ (Kv7, “M-type”) K+ currents in neurons
Vigil, F. A., Bozdemir, E., Bugay, V., Chun, S. H., Hobbs, M. A., Sanchez, I., Hastings, S. D., Veraza, R. J., Holstein, D. M., Sprague, S. M., M Carver, C., Cavazos, J. E., Brenner, R., Lechleiter, J. D. & Shapiro, M. S., Jun 1 2020, In : Journal of Cerebral Blood Flow and Metabolism. 40, 6, p. 1256-1273 18 p.Research output: Contribution to journal › Article
5
Scopus
citations
Time to Target Stroke: Examining the Circadian System in Stroke
Stubblefield, J. J. & Lechleiter, J. D., Jun 1 2019, In : The Yale journal of biology and medicine. 92, 2, p. 349-357 9 p.Research output: Contribution to journal › Review article
1
Scopus
citations
Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer’s disease and vascular cognitive impairment
Van Skike, C. E., Jahrling, J. B., Olson, A. B., Sayre, N. L., Hussong, S. A., Ungvari, Z., Lechleiter, J. D. & Galvan, V., Apr 1 2018, In : American Journal of Physiology - Heart and Circulatory Physiology. 314, 4, p. H693-H703Research output: Contribution to journal › Article
24
Scopus
citations
The long-term effect of maternal dietary protein restriction on 5-HT1A receptor function and behavioral responses to stress in adulthood
Ye, W., Pitlock, M. D., Javors, M. A., Thompson, B. J., Lechleiter, J. D. & Hensler, J. G., Jan 1 2018, (Accepted/In press) In : Behavioural Brain Research.Research output: Contribution to journal › Article
2
Scopus
citations
Press / Media
Candidacy Ceremony 2020 version
Barbara A Christy, Lily Q Dong, Nu Zhang, Teppei Fujikawa, Carie Boychuk, Jessica Nute, Karl Rasmussen, James F Nelson, Kenneth M Hargreaves, Erzsebet K Cearley, Azizeh K Sowan, Pei Wang, Tyler J Curiel, Alexander J Bishop, Thomas G Boyer, Sara L Gill, Alan Frazer, Lisa M Cleveland, James D Lechleiter, Kexin Xu, Lizhen Chen, Paolo Casali, Kumar Sharma, Sarah C Hopp, Evelien M Bunnik, Susan E Frost, Elizabeth Leadbetter & Patrick M Sung
8/31/20
1 item of Media coverage
Press/Media: Press / Media
Novel therapy administered after TBI prevents brain damage
Mark S Shapiro, Robert Brenner & James D Lechleiter
7/16/19 → 7/17/19
4 items of Media coverage
Press/Media: Press / Media
University of Texas Health Science Center-San Antonio: Novel Therapy Administered After TBI Prevents Brain Damage
Mark S Shapiro, Robert Brenner & James D Lechleiter
7/13/19
1 item of Media coverage
Press/Media: Press / Media
Global Neuroprotection Drugs Market is Expected
7/11/19
1 item of Media coverage
Press/Media: Press / Media
Global Neuroprotection Drugs Market is Expected to Reach US$ 33,481.7 Million by 2027, Growing at an Estimated CAGR of 1.56% Over the Forecast Period, Says Absolute Markets Insights
7/11/19
8 items of Media coverage
Press/Media: Press / Media